Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) increased in the highest treatment group, indicating liver dysfunction, with the elevated ALP level also indicating bone damage. The gene discussed is GPT; the disease is Decreased liver function.